GLENMARK PHARMACEUTICALS Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹3,901 Cr | ₹6,047 Cr | ₹3,264 Cr | ₹3,256 Cr | ₹3,388 Cr | ₹3,434 Cr | ₹3,244 Cr | ₹3,063 Cr |
| Expenses | ₹3,031 Cr | ₹3,687 Cr | ₹2,684 Cr | ₹2,695 Cr | ₹2,787 Cr | ₹2,832 Cr | ₹2,656 Cr | ₹2,559 Cr |
| Operating Income | ₹870 Cr | ₹2,360 Cr | ₹581 Cr | ₹561 Cr | ₹600 Cr | ₹602 Cr | ₹588 Cr | ₹504 Cr |
| Other Income | ₹44 Cr | ₹201 Cr | ₹26 Cr | ₹12 Cr | ₹31 Cr | ₹39 Cr | ₹31 Cr | ₹773 Cr |
| Interest | ₹41 Cr | ₹66 Cr | ₹58 Cr | ₹67 Cr | ₹52 Cr | ₹48 Cr | ₹40 Cr | ₹149 Cr |
| Depreciation | ₹154 Cr | ₹141 Cr | ₹130 Cr | ₹125 Cr | ₹123 Cr | ₹120 Cr | ₹118 Cr | ₹151 Cr |
| Profit Before Tax | ₹534 Cr | ₹967 Cr | ₹96 Cr | ₹8 Cr | ₹456 Cr | ₹473 Cr | ₹462 Cr | ₹531 Cr |
| Profit After Tax | ₹403 Cr | ₹610 Cr | ₹47 Cr | ₹4 Cr | ₹348 Cr | ₹354 Cr | ₹340 Cr | ₹-1,239 Cr |
| EPS | ₹14.29 | ₹21.63 | ₹1.66 | ₹0.16 | ₹12.33 | ₹12.55 | ₹12.06 | ₹-43.17 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLENMARK PHARMACEUTICALS | -1.6% | -5.3% | 31.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 7.1% | -1.5% | -6.2% |
| DIVIS LABORATORIES | 2.8% | -2.8% | 6% |
| CIPLA | 0.2% | -12.5% | -7.9% |
| TORRENT PHARMACEUTICALS | 3.1% | 4.2% | 18.8% |
| DR REDDYS LABORATORIES | 2.2% | -1.6% | 0% |
| MANKIND PHARMA | 2.6% | -2.1% | -16.6% |
| ZYDUS LIFESCIENCES | 1.4% | -1.5% | -5.7% |
| LUPIN | 2.6% | 3.8% | 2.9% |
GLENMARK PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -35.49 % |
| Y-o-Y | 15.15 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹3,901 Cr | -35.49 | |
| Sep2025 | ₹6,047 Cr | 85.23 | |
| Jun2025 | ₹3,264 Cr | 0.25 | |
| Mar2025 | ₹3,256 Cr | -3.88 | |
| Dec2024 | ₹3,388 Cr | -1.35 | |
| Sep2024 | ₹3,434 Cr | 5.84 | |
| Jun2024 | ₹3,244 Cr | 5.92 | |
| Mar2024 | ₹3,063 Cr | - | |
GLENMARK PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -63.14 % |
| Y-o-Y | 44.90 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹870 Cr | -63.14 | |
| Sep2025 | ₹2,360 Cr | 306.45 | |
| Jun2025 | ₹581 Cr | 3.47 | |
| Mar2025 | ₹561 Cr | -6.53 | |
| Dec2024 | ₹600 Cr | -0.28 | |
| Sep2024 | ₹602 Cr | 2.33 | |
| Jun2024 | ₹588 Cr | 16.63 | |
| Mar2024 | ₹504 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -42.85 % |
| Y-o-Y | 25.85 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 22.3% | -42.85 | |
| Sep2025 | 39.02% | 119.46 | |
| Jun2025 | 17.78% | 3.19 | |
| Mar2025 | 17.23% | -2.77 | |
| Dec2024 | 17.72% | 1.08 | |
| Sep2024 | 17.53% | -3.31 | |
| Jun2024 | 18.13% | 10.08 | |
| Mar2024 | 16.47% | - | |
GLENMARK PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -33.94 % |
| Y-o-Y | 15.86 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹403 Cr | -33.94 | |
| Sep2025 | ₹610 Cr | 1,199.54 | |
| Jun2025 | ₹47 Cr | 971.46 | |
| Mar2025 | ₹4 Cr | -98.74 | |
| Dec2024 | ₹348 Cr | -1.82 | |
| Sep2024 | ₹354 Cr | 4.19 | |
| Jun2024 | ₹340 Cr | Positive | |
| Mar2024 | ₹-1,239 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 2.38 % |
| Y-o-Y | 0.68 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 10.34 % | 2.38 | |
| Sep2025 | 10.1 % | 601.39 | |
| Jun2025 | 1.44 % | 1,007.69 | |
| Mar2025 | 0.13 % | -98.73 | |
| Dec2024 | 10.27 % | -0.48 | |
| Sep2024 | 10.32 % | -1.62 | |
| Jun2024 | 10.49 % | Positive | |
| Mar2024 | -40.44 % | - | |
GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -33.93 % |
| Y-o-Y | 15.90 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹14.29 | -33.93 | |
| Sep2025 | ₹21.63 | 1,203.01 | |
| Jun2025 | ₹1.66 | 937.50 | |
| Mar2025 | ₹0.16 | -98.70 | |
| Dec2024 | ₹12.33 | -1.75 | |
| Sep2024 | ₹12.55 | 4.06 | |
| Jun2024 | ₹12.06 | Positive | |
| Mar2024 | ₹-43.17 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD